Natural history of myocardial deformation in children, adolescents, and young adults exposed to anthracyclines: Systematic review and meta-analysis.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 8511187 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-8175 (Electronic) Linking ISSN: 07422822 NLM ISO Abbreviation: Echocardiography Subsets: MEDLINE
    • Publication Information:
      Publication: Hoboken, NJ : Wiley-Blackwell
      Original Publication: Mount Kisco, N.Y. : Futura Pub. Co., [c1984-
    • Subject Terms:
    • Abstract:
      Objective: Anthracyclines are widely used to treat solid and hematologic malignancies, but are known to cause cardiotoxicity. As more childhood cancer survivors reach adulthood due to improvements in oncologic treatments, they become susceptible to late and progressive anthracycline-induced cardiotoxicity. Nonetheless, diagnostic criteria for early detection of cardiac dysfunction are not well defined in children, adolescent, and young adults (CAYA, ages 1-40 years). We present a natural history of the changes in myocardial deformation in CAYA patients after anthracycline therapy.
      Methods: We performed a literature review search between 2001 and 2016 using PubMed with the following search terms: strain (or deformation), torsion (or twist), children (or adolescent or young adult), cardiotoxicity (or dysfunction), and anthracyclines (or doxorubicin). A total of 23 articles were reviewed. Fourteen articles were incorporated in the meta-analysis.
      Results: Strain abnormalities are observed at both short-term and long-term follow-up. Global longitudinal strain (GLS) abnormalities are common during or early after chemotherapy, whereas changes in global circumferential strain (GCS) are more significant and consistent on long-term follow-up. Although global radial strain and torsional parameters are also often abnormal late after chemotherapy, there are few studies evaluating these parameters.
      Conclusion: There are significant abnormalities in GLS and GCS following anthracycline therapy acutely and late after treatment. The prognostic value of these strain abnormalities warrants further investigation.
      (© 2018 Wiley Periodicals, Inc.)
    • References:
      Epidemiol Rev. 1992;14:154-76. (PMID: 1289110)
      BMJ. 2003 Sep 6;327(7414):557-60. (PMID: 12958120)
      Pediatr Blood Cancer. 2005 Jun 15;44(7):600-6. (PMID: 15856486)
      Lancet. 1991 Apr 6;337(8745):816-8. (PMID: 1672914)
      Am J Cardiol. 2007 Apr 1;99(7):974-7. (PMID: 17398195)
      J Am Soc Echocardiogr. 2007 Dec;20(12):1351-8. (PMID: 17604960)
      PLoS Med. 2009 Jul 21;6(7):e1000097. (PMID: 19621072)
      Korean Circ J. 2009 Sep;39(9):352-8. (PMID: 19949618)
      J Am Coll Cardiol. 2010 Jan 19;55(3):213-20. (PMID: 20117401)
      J Am Soc Echocardiogr. 2010 Apr;23(4):351-69; quiz 453-5. (PMID: 20362924)
      Heart. 2010 Jul;96(14):1137-41. (PMID: 20511624)
      JAMA. 2010 Jul 14;304(2):172-9. (PMID: 20628130)
      Ultrasound Med Biol. 2010 Nov;36(11):1783-91. (PMID: 20870348)
      J Am Soc Echocardiogr. 2011 Mar;24(3):277-313. (PMID: 21338865)
      J Am Soc Echocardiogr. 2011 Jun;24(6):625-36. (PMID: 21392941)
      Clin Cardiol. 2011 May;34(5):288-93. (PMID: 21557254)
      Echocardiography. 2011 Aug;28(7):738-45. (PMID: 21615484)
      J Am Soc Echocardiogr. 2011 Nov;24(11):1253-9. (PMID: 21908174)
      Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):1996-2005. (PMID: 21980007)
      ISRN Pediatr. 2012;2012:870549. (PMID: 22518327)
      J Am Soc Echocardiogr. 2012 Jul;25(7):733-40. (PMID: 22578518)
      Fetal Diagn Ther. 2012;32(1-2):5-16. (PMID: 22584107)
      Curr Cardiol Rev. 2011 Nov;7(4):214-20. (PMID: 22758622)
      Eur Heart J Cardiovasc Imaging. 2013 Feb;14(2):175-82. (PMID: 22802431)
      J Card Fail. 2012 Aug;18(8):607-13. (PMID: 22858075)
      Asia Pac J Clin Oncol. 2012 Dec;8(4):368-74. (PMID: 22898185)
      Ann Oncol. 2012 Oct;23 Suppl 7:vii155-66. (PMID: 22997448)
      Eur Heart J Cardiovasc Imaging. 2013 Jun;14(6):562-9. (PMID: 23109647)
      J Am Soc Echocardiogr. 2013 Feb;26(2):185-91. (PMID: 23218891)
      J Am Soc Echocardiogr. 2013 Aug;26(8):846-52. (PMID: 23727115)
      Cardiol Young. 2014 Oct;24(5):854-65. (PMID: 24044518)
      Circ Cardiovasc Imaging. 2013 Nov;6(6):873-80. (PMID: 24097420)
      Nat Rev Clin Oncol. 2013 Dec;10(12):697-710. (PMID: 24165948)
      PLoS One. 2013 Oct 21;8(10):e77063. (PMID: 24204736)
      J Cancer Surviv. 2014 Jun;8(2):183-9. (PMID: 24317971)
      J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2751-68. (PMID: 24703918)
      Pediatr Blood Cancer. 2015 Mar;62(3):502-8. (PMID: 25393686)
      Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):1-11. (PMID: 25525063)
      Syst Rev. 2015 Jan 01;4:1. (PMID: 25554246)
      Ultrasound Med Biol. 2015 Mar;41(3):627-43. (PMID: 25619777)
      Balkan Med J. 2015 Jan;32(1):56-63. (PMID: 25759773)
      Pediatr Blood Cancer. 2015 Aug;62(8):1437-43. (PMID: 25832752)
      Pediatr Cardiol. 2015 Dec;36(8):1610-6. (PMID: 26049414)
      J Am Coll Cardiol. 2015 Jun 16;65(23):2511-22. (PMID: 26065990)
      Cardiovasc Ultrasound. 2015 Aug 07;13:37. (PMID: 26250696)
      Pediatr Cardiol. 2016 Mar;37(3):537-44. (PMID: 26667956)
      J Am Soc Echocardiogr. 2016 Mar;29(3):209-225.e6. (PMID: 26747685)
      Biomed Res Int. 2016;2016:9363951. (PMID: 26942202)
      Cancer Treat Rep. 1981;65 Suppl 4:3-8. (PMID: 7049379)
    • Grant Information:
      UL1 TR000124 United States TR NCATS NIH HHS; UL1 TR001881 United States TR NCATS NIH HHS
    • Contributed Indexing:
      Keywords: cardiac toxicity; myocardial strain; transthoracic echocardiography
    • Accession Number:
      0 (Anthracyclines)
    • Publication Date:
      Date Created: 20180401 Date Completed: 20181105 Latest Revision: 20240918
    • Publication Date:
      20240918
    • Accession Number:
      PMC6544758
    • Accession Number:
      10.1111/echo.13871
    • Accession Number:
      29603386